These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26514175)

  • 1. Radiopeptides for Imaging and Therapy: A Radiant Future.
    Chatalic KL; Kwekkeboom DJ; de Jong M
    J Nucl Med; 2015 Dec; 56(12):1809-12. PubMed ID: 26514175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor imaging and therapy using radiolabeled somatostatin analogues.
    de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
    Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptors as targets for nuclear medicine imaging and radionuclide treatment.
    Maecke HR; Reubi JC
    J Nucl Med; 2011 Jun; 52(6):841-4. PubMed ID: 21571797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What can gallium-68 PET add to receptor and molecular imaging?
    Al-Nahhas A; Win Z; Szyszko T; Singh A; Khan S; Rubello D
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):1897-901. PubMed ID: 17713764
    [No Abstract]   [Full Text] [Related]  

  • 5. Somatostatin receptor PET imaging with Gallium-68 labeled peptides.
    Win Z; Al-Nahhas A; Rubello D; Gross MD
    Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):244-50. PubMed ID: 17464267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLP-1 and exendin-4 for imaging endocrine pancreas. A review. Labelled glucagon-like peptide-1 analogues: past, present and future.
    Hubalewska-Dydejczyk A; Sowa-Staszczak A; Tomaszuk M; Stefańska A
    Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):152-60. PubMed ID: 25719487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging.
    Roosenburg S; Laverman P; Joosten L; Eek A; Rutjes FP; van Delft FL; Boerman OC
    Mol Imaging; 2012; 11(5):401-7. PubMed ID: 22954184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radionuclide imaging of neurendocrine tumors: biological basis and diagnostic results].
    Genovese EA; Mallardo V; Rossi M; Vaccaro A; Raucci A; Della Vecchi N; Romano G; Califano T; Schillirò F
    Recenti Prog Med; 2013; 104(7-8):340-4. PubMed ID: 24042404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.
    Kwekkeboom DJ; Kam BL; van Essen M; Teunissen JJ; van Eijck CH; Valkema R; de Jong M; de Herder WW; Krenning EP
    Endocr Relat Cancer; 2010 Mar; 17(1):R53-73. PubMed ID: 19995807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallium-68 PET: a new frontier in receptor cancer imaging.
    Al-Nahhas A; Win Z; Szyszko T; Singh A; Nanni C; Fanti S; Rubello D
    Anticancer Res; 2007; 27(6B):4087-94. PubMed ID: 18225576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second world congress on 68Ga molecular imaging.
    Schultz MK
    J Nucl Med; 2012 Jul; 53(7):14N. PubMed ID: 22753426
    [No Abstract]   [Full Text] [Related]  

  • 12. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.
    Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B
    J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient selection for personalized peptide receptor radionuclide therapy using Ga-68 somatostatin receptor PET/CT.
    Kulkarni HR; Baum RP
    PET Clin; 2014 Jan; 9(1):83-90. PubMed ID: 25029937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabeled peptides in diagnosis and tumor imaging: clinical overview.
    Warner RR; O'dorisio TM
    Semin Nucl Med; 2002 Apr; 32(2):79-83. PubMed ID: 11965602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabeled bicyclic somatostatin-based analogs: a novel class of potential radiotracers for SPECT/PET of neuroendocrine tumors.
    Fani M; Mueller A; Tamma ML; Nicolas G; Rink HR; Cescato R; Reubi JC; Maecke HR
    J Nucl Med; 2010 Nov; 51(11):1771-9. PubMed ID: 20956465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallium and other agents in diseases of the lung.
    Schuster DM; Alazraki N
    Semin Nucl Med; 2002 Jul; 32(3):193-211. PubMed ID: 12105800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives.
    Breeman WA; de Blois E; Sze Chan H; Konijnenberg M; Kwekkeboom DJ; Krenning EP
    Semin Nucl Med; 2011 Jul; 41(4):314-21. PubMed ID: 21624565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targeting.
    Ginj M; Zhang H; Eisenwiener KP; Wild D; Schulz S; Rink H; Cescato R; Reubi JC; Maecke HR
    Clin Cancer Res; 2008 Apr; 14(7):2019-27. PubMed ID: 18381940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theranostics with Ga-68 somatostatin receptor PET/CT: monitoring response to peptide receptor radionuclide therapy.
    Kulkarni HR; Baum RP
    PET Clin; 2014 Jan; 9(1):91-7. PubMed ID: 25029938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide receptor imaging and therapy.
    Kwekkeboom D; Krenning EP; de Jong M
    J Nucl Med; 2000 Oct; 41(10):1704-13. PubMed ID: 11038002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.